[go: up one dir, main page]

BR0214289A - Composição de bebida compreendendo um composto de boro definido, método de preparação da mesma, kit compreendendo a mesma e uso da mesma na fabricação de um medicamento - Google Patents

Composição de bebida compreendendo um composto de boro definido, método de preparação da mesma, kit compreendendo a mesma e uso da mesma na fabricação de um medicamento

Info

Publication number
BR0214289A
BR0214289A BR0214289-9A BR0214289A BR0214289A BR 0214289 A BR0214289 A BR 0214289A BR 0214289 A BR0214289 A BR 0214289A BR 0214289 A BR0214289 A BR 0214289A
Authority
BR
Brazil
Prior art keywords
compositions
kit
preparing
manufacture
beverage composition
Prior art date
Application number
BR0214289-9A
Other languages
English (en)
Inventor
Raymond Louis Niehoff
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25535315&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0214289(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR0214289A publication Critical patent/BR0214289A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/22—Boron compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof containing fruit or vegetable juices
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/54—Mixing with gases
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPOSIçãO DE BEBIDA COMPREENDENDO UM COMPOSTO DE BORO DEFINIDO, MéTODO DE PREPARAçãO DA MESMA, KIT COMPREENDENDO A MESMA E USO DA MESMA NA FABRICAçãO DE UM MEDICAMENTO". A presente invenção refere-se a composições que contêm boro, as quais são úteis para diversas finalidades, incluindo melhora da saúde óssea, alívio de artrite, dor e inflamação, além de oferecer outros efeitos benéficos à saúde. A presente invenção refere-se também aos métodos para a preparação de tais composições, aos métodos de uso (incluindo a administração) das composições, bem como aos kits contendo as composições. As composições têm um pH que é pelo menos cerca de duas unidades de pH abaixo do pKa do composto de boro.
BR0214289-9A 2001-11-20 2002-11-15 Composição de bebida compreendendo um composto de boro definido, método de preparação da mesma, kit compreendendo a mesma e uso da mesma na fabricação de um medicamento BR0214289A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/989,641 US6632449B2 (en) 2001-11-20 2001-11-20 Compositions and kits comprising a defined boron compound and methods of their preparation
PCT/US2002/036531 WO2003043617A1 (en) 2001-11-20 2002-11-15 Compositions and kits comprising a defined boron compound, methods of their preparation, and use and administration thereof

Publications (1)

Publication Number Publication Date
BR0214289A true BR0214289A (pt) 2004-09-21

Family

ID=25535315

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0214289-9A BR0214289A (pt) 2001-11-20 2002-11-15 Composição de bebida compreendendo um composto de boro definido, método de preparação da mesma, kit compreendendo a mesma e uso da mesma na fabricação de um medicamento

Country Status (9)

Country Link
US (1) US6632449B2 (pt)
EP (2) EP1450776A1 (pt)
JP (1) JP2005509661A (pt)
CN (2) CN101371710A (pt)
AU (1) AU2002346396A1 (pt)
BR (1) BR0214289A (pt)
CA (1) CA2463668C (pt)
MX (1) MXPA04004732A (pt)
WO (1) WO2003043617A1 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040253296A1 (en) * 2002-09-11 2004-12-16 Martin Kenneth A. Food bar for treating musculoskeletal disorders
WO2006042479A1 (fr) * 2004-10-22 2006-04-27 Shin-Jen Shiao Composition pharmaceutique et cafe n’engendrant pas de dependence, comprenant de l’acide carboxylique comestible et/ou son sel acide et de la cafeine
US8007846B2 (en) 2006-01-18 2011-08-30 Albion International, Inc. Mixed amino acid/mineral compounds having improved solubility
ES2609976T3 (es) * 2006-01-27 2017-04-25 Yale University Combinación de sal de cinc y agente anti-H. pylori como inhibidor de acción rápida de la secreción de ácido gástrico
US20080118603A1 (en) * 2006-11-21 2008-05-22 Lada Mark W Nutritional beverage for optimal bone health
US9314048B2 (en) 2007-03-14 2016-04-19 The Concentrate Manufacturing Company Of Ireland Beverage products with non-nutritive sweetener and bitterant
US8029846B2 (en) 2007-03-14 2011-10-04 The Concentrate Manufacturing Company Of Ireland Beverage products
US8277862B2 (en) 2007-03-14 2012-10-02 Concentrate Manufacturing Company Of Ireland Beverage products having steviol glycosides and at least one acid
US20080226790A1 (en) * 2007-03-14 2008-09-18 Concentrate Manufacturing Company Of Ireland Long chain fatty acids for reducing off-taste of non-nutritive sweeteners
US8084073B2 (en) 2007-03-14 2011-12-27 Concentrate Manufacturing Company Of Ireland Anisic acid modified steviol glycoside sweetened beverage products
US8277861B2 (en) 2007-03-14 2012-10-02 Concentrate Manufacturing Company Of Ireland Beverage products having steviol glycosides and at least one acid
US9877500B2 (en) 2007-03-14 2018-01-30 Concentrate Manufacturing Company Of Ireland Natural beverage products
US20090162484A1 (en) * 2007-12-21 2009-06-25 The Concentrate Manufacturing Company Of Ireland Beverage having a non-sweetening amount of a potent natural sweetener
IT1395957B1 (it) 2009-05-19 2012-11-02 Pharmaguida S R L Uso di una combinazione di d-aspartato e l-aspartato per il trattamento della infertilita' maschile.
US9913810B2 (en) 2009-07-23 2018-03-13 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using phospholipids and astaxanthin
US9402857B2 (en) 2009-07-23 2016-08-02 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin
US8557275B2 (en) 2009-07-23 2013-10-15 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
US9399047B2 (en) 2009-07-23 2016-07-26 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using phospholipids and roe extract
US9238043B2 (en) 2009-07-23 2016-01-19 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using algae based oils
US9216164B2 (en) 2009-07-23 2015-12-22 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
MX2012006923A (es) * 2009-12-18 2012-07-10 Stokely Van Camp Inc Bebida de recuperacion con proteina.
US9763897B2 (en) 2010-04-30 2017-09-19 U.S. Nutraceuticals, LLC Therapeutic astaxanthin and phospholipid composition and associated method
SG189046A1 (en) * 2010-09-23 2013-05-31 Tata Global Beverages Ltd Calcium fortifying composition for strength, a hydration supplement, and process for preparing the same
WO2012038985A2 (en) * 2010-09-23 2012-03-29 Tata Global Beverages Limited Trivalent chromium and boron fortifying composition, a hydration supplement, and process for preparing the same
ITAN20110027A1 (it) * 2011-02-25 2012-08-26 Ht Health Trade S R L Miscela di principi funzionali atti ad integrare il ferro nella dieta umana.
WO2015142705A1 (en) * 2014-03-18 2015-09-24 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition and method to alleviate joint pain using algae based oils
CN106723065A (zh) * 2017-01-12 2017-05-31 浙江格蕾斯生物科技有限公司 一种维生素d和硼复合营养补充剂

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2255341A (en) * 1939-04-13 1941-09-09 Fruit Growers Exchange Ca Composition of citrus fruit constituents and boric acid and method for making the same
US2661349A (en) 1949-02-18 1953-12-01 Nat Starch Products Inc Polysaccharide derivatives of substituted dicarboxylic acids
US3455838A (en) 1966-04-22 1969-07-15 Nat Starch Chem Corp Method of encapsulating water-insoluble substances and product thereof
US4338346A (en) 1978-12-21 1982-07-06 The Procter & Gamble Company Non-nutritive sweetener
US4863748A (en) 1979-08-30 1989-09-05 Herschler R J Dietary products and uses comprising methylsulfonylmethane
US4411925A (en) 1980-01-21 1983-10-25 Pfizer Inc. Branched amides of L-aspartyl-d-amino acid dipeptides
US4399163A (en) 1980-11-05 1983-08-16 Pfizer Inc. Branched amides of L-aspartyl-D-amino acid dipeptides
US4423029A (en) 1981-06-25 1983-12-27 The Procter & Gamble Company (S)-3-Amino-4-[(S,S)-1-(1-hydroxyethyl)alkyl amino]-4-oxo-butyric acid compounds suitable as non-nutritive sweetners
US4668525A (en) 1982-01-05 1987-05-26 Thomas J. Lipton, Inc. Tea extraction process
US4460617A (en) 1982-06-04 1984-07-17 National Starch And Chemical Corp. Protein-free coffee whitener and method of making same
US4680193A (en) 1985-05-08 1987-07-14 Nestec S.A. Solubilization of tea in cold water with catechin
US4705690A (en) 1985-11-18 1987-11-10 The Procter & Gamble Co. Weighting oil substitutes
US4705691A (en) 1985-11-18 1987-11-10 The Procter & Gamble Co. Beverage opacifier
US4737375A (en) 1985-12-26 1988-04-12 The Procter & Gamble Company Beverages and beverage concentrates nutritionally supplemented with calcium
US4830716B1 (en) 1986-07-03 1999-12-07 Albion Int Preparation of pharmaceutical grade amino acid chelates
US4786518A (en) 1987-07-02 1988-11-22 The Procter & Gamble Company Iron mineral supplements
US5118513A (en) 1987-07-02 1992-06-02 The Procter & Gamble Company Method for enhancing bioavailability of iron-calcium mineral supplements
US4786510A (en) 1987-07-02 1988-11-22 The Procter & Gamble Company Calcium-iron mineral supplements
US4994283A (en) 1987-07-02 1991-02-19 The Procter & Gamble Company Iron-calcium mineral supplements with enhanced bioavailability
US5128374A (en) 1987-08-28 1992-07-07 The Procter & Gamble Company Use of calcium citrate malate for the treatment of osteoporosis and related disorders
US5314919A (en) 1987-08-28 1994-05-24 The Procter & Gamble Company Calcium supplements
US5225221A (en) 1987-12-28 1993-07-06 The Procter & Gamble Company Preparation of calcium-supplemented beverages by dispersing calcium hydroxide in pasteurized juice stream
US4849220A (en) 1988-04-20 1989-07-18 The United States Of America As Represented By The Secretary Of Agriculture Use of boron supplements to increase in vivo production of hydroxylated steroids
US4935256A (en) 1989-10-31 1990-06-19 Procter & Gamble Company Process for making green tea solids
US5186965A (en) 1990-06-14 1993-02-16 The Procter & Gamble Company Calcium citrate malate composition
US5151274A (en) 1990-08-06 1992-09-29 The Procter & Gamble Company Calcium and trace mineral supplements
US5232709A (en) 1990-08-06 1993-08-03 The Procter & Gamble Company Calcium and trace mineral supplements comprising estrogen
US5108761A (en) 1990-10-01 1992-04-28 The Procter & Gamble Company Method of preventing tooth enamel erosion utilizing an acidic beverage containing calcium
JPH06502310A (ja) 1990-10-31 1994-03-17 ザ、プロクター、エンド、ギャンブル、カンパニー カルシウム強化ソース
AU3240193A (en) 1991-12-26 1993-07-28 Procter & Gamble Company, The Storage stable calcium-supplemented beverage concentrates
US5389387A (en) 1991-12-26 1995-02-14 The Procter & Gamble Company Storage stable calcium-supplemented beverage concentrates
US5292729A (en) 1992-08-14 1994-03-08 Albion International, Inc. II-bond aromatic vitamin chelates
ATE140125T1 (de) 1992-10-21 1996-07-15 Procter & Gamble Lagerfähige, kalziumzusatzenthaltende getränkekonzentrate und sirup
ATE147593T1 (de) 1992-10-21 1997-02-15 Procter & Gamble Eine konzentrierte lebensverfügbare kalziumsquelle enthaltender süssstof
JP3199742B2 (ja) 1992-10-21 2001-08-20 ザ、プロクター、エンド、ギャンブル、カンパニー 濃縮された生物学的利用性カルシウム源
US5433965A (en) 1993-02-16 1995-07-18 The Procter & Gamble Company Beverage compositions and sweetening compositions which contain juice derived from botanical subfamily Cucurbitaceae
US5364845C1 (en) 1993-03-31 2002-09-10 Nutramax Lab Inc Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue
US5424082A (en) 1994-03-03 1995-06-13 The Proctor & Gamble Company Calcium and vitamin C containing beverage products with improved color stability
US5474793A (en) 1994-05-10 1995-12-12 Meyer; Larry E. Process for preparing calcium-supplemented not-from-concentrate fruit juice beverages
US5516925A (en) 1994-08-23 1996-05-14 Albion International, Inc. Amino acid chelates having improved palatability
IL115241A (en) 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
US5571441A (en) 1994-11-01 1996-11-05 The Procter & Gamble Company Nutrient supplement compositions providing physiologic feedback
US5612026A (en) 1996-01-25 1997-03-18 The Procter & Gamble Company Cholesterol lowering drink mix compositons
US5670344A (en) 1996-02-02 1997-09-23 The Procter & Gamble Company Preventing undesired color formation in iron fortified chocolate-flavored beverages by including edible acids or their salts
US6063428A (en) 1996-02-26 2000-05-16 The Procter & Gamble Company Green tea extract subjected to cation exchange treatment and nanofiltration to improve clarity and color
US5707670A (en) 1996-08-29 1998-01-13 The Procter & Gamble Company Use of bilayer forming emulsifiers in nutritional compositions comprising divalent mineral salts to minimize off-tastes and interactions with other dietary components
US5962049A (en) * 1997-03-31 1999-10-05 Miljkovic; Dusan Boron carbohydrate complexes and uses thereof
US6007856A (en) 1997-08-08 1999-12-28 The Procter & Gamble Company Oil-in-water dispersions of β-carotene and other carotenoids stable against oxidation prepared from water-dispersible beadlets having high concentrations of carotenoid
US6475539B1 (en) * 1998-05-07 2002-11-05 Abbott Laboratories Nutritionally complete low pH enteral formula
US6162787A (en) * 1999-04-02 2000-12-19 Immudyne, Inc. Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions
US6458383B2 (en) * 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
US6413558B1 (en) * 1999-07-19 2002-07-02 The Proctor & Gamble Co. Compositions, kits, and methods for providing and maintaining energy and metal alertness
US20020132780A1 (en) * 2001-01-12 2002-09-19 Heisey Matthew Thomas Low carbohydrate compositions, kits thereof, and methods of use

Also Published As

Publication number Publication date
CA2463668A1 (en) 2003-05-30
CA2463668C (en) 2010-06-15
AU2002346396A1 (en) 2003-06-10
US6632449B2 (en) 2003-10-14
CN101371710A (zh) 2009-02-25
WO2003043617A1 (en) 2003-05-30
MXPA04004732A (es) 2004-07-30
EP1450776A1 (en) 2004-09-01
JP2005509661A (ja) 2005-04-14
US20030096794A1 (en) 2003-05-22
EP2266551A1 (en) 2010-12-29
CN1589134A (zh) 2005-03-02

Similar Documents

Publication Publication Date Title
BR0214289A (pt) Composição de bebida compreendendo um composto de boro definido, método de preparação da mesma, kit compreendendo a mesma e uso da mesma na fabricação de um medicamento
BR9714082A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto.
BR9907270A (pt) Composto, composição farmacêutica, uso de um composto, e, processos para tratamento ou profilaxia de doenças inflamatórias, por exemplo, asma ou copd, e para a preparação de um composto
BR9911482A (pt) Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto
BR0214705A (pt) Composição, seu uso, método para prevenção ou tratamento de doença neurodegenerativa, e kit
BR9911488A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto
RS20090083A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta -mimetics
BR9714055A (pt) Composto, uso do mesmo, agente de diagnóstico, composição farmacêutica, e, processos para a preparação de um composto, para o tratamento da dor, tratamento de distúrbios gastrointestinais e de ferimentos na coluna vertebral.
BR0213612A (pt) Composto, composição farmacêutica, uso do composto e método para tratamento de doença ou condição
BG105005A (en) Pyrazoline derivatives, their preparation and application as medicaments
UY24354A1 (es) Composiciones farmacéuticas que contienen epinastina
BRPI0215312B8 (pt) composto, uso de um composto, composição farmacêutica, e processo para a preparação de um composto
AR037517A1 (es) Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria
BR0012488A (pt) Composição farmacêutica, métodos para melhorar a taxa de absorção de um ou mais do que um agente farmaceuticamente ativo em mamìferos, para melhorar o inìcio do benefìcio terapêutico de um ou mais do que um agente farmaceuticamente ativo em mamìferos, para inibição de gastroirritação em um mamìfero, e para tratamento de mamìferos necessitando do tratamento proporcionado por um ou mais do que um agente farmaceuticamente ativo, e, processo para preparar uma composição farmacêutica
BR9713785A (pt) Composto, uso do mesmo, agente de diagnóstico, composição farmacêutica, e, processos para a preparação de um composto e para o tratamento da dor, de distúrbios gastrointestinais e de lesões na coluna vertebral.
AR023574A1 (es) Compuestos de azepinindol tetraciclico,composiciones farmaceuticas y el uso de dichos compuestos para preparar un medicamento, e intermediarios
PT1326613E (pt) Utilizacao de derivados de imidazo[1,2-a]piridin-,imidazo[1,2-a]pirimidin- e imidazo[1,2-a]pirazin-3-il-amina substituidos para a fabricacao de medicamentos para inibicao de nos
DE69940769D1 (de) Orale flüssige zusammensetzungen
BR9912240A (pt) Benzocicloheptenos, processo para a sua preparação, preparados farmacêuticos, que contêm os mesmos bem como seu emprego para a preparação de medicamentos
BRPI0407253A (pt) Heterociclil-3-sulfonilindazóis como ligandos 5-hidroxitriptamina-6 processo de preparação dos mesmos, seus usos na preparação de uma composição farmacêutica e composição farmacêutica compreendendo os referidos compostos
BR0206935A (pt) Composto, formulação farmacêutica, uso de um composto, método de tratamento e/ou profilaxia de condições associadas com a inibição da glicogênio sintase quinase-3, e, processo para a preparação de um composto
BRPI0406717A (pt) Composto, composição farmacêutica que compreende o mesmo, método de tratamento de uma enfermidade em um mamìfero, utilização do composto e processo para a sua produção
BR0109672A (pt) Uso de zd6126 ou de um seu sal farmaceuticamente aceitável e um de: um agente antitumoral de plantina e um taxano, composição farmacêutica, produto de combinação, kit, e, método para a produção de um efeito de danificação vascular em um animal de sangue quente
HUP0100539A2 (hu) D-vitamint és kálciumot tartalmazó gyógyászati készítmények és eljárás azok előállítására
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: SD IP HOLDINGS COMPANY (US)

Free format text: TRANSFERIDO DE: THE PROCTER AND GAMBLE COMPANY

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA INT.CL: A61K 31/00, A23L 1/30, A23L 2/00, A61K 33/22, A23L 1/304, A61P 19/00, A61P 269/00

Ipc: A61K 31/00 (2011.01), A23L 1/30 (2011.01), A23L 2/

B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B15K Others concerning applications: alteration of classification

Ipc: A61K 33/22 (2006.01), A23L 2/02 (2006.01), A23L 2/

B11T Dismissal: dismissal of application maintained